[...]to insulin pump therapy, which is often associated with an improved quality of life, CGM can be burdensome, with qualitative data suggesting that for these women the CGM burdens (discomfort, sensor inaccuracy, sleep disturbances) outweighed the potential benefits (8). Because the CGM data were blinded, women were unburdened by alarms or sensor inaccuracy, which may have assisted compliance.
© 2001-2025 Fundación Dialnet · Todos los derechos reservados